AbbVie’s oral CGRP inhibitor Qulipta (atogepant) is also under review by NICE for migraine prevention, with a decision due in mid-August. “On top of debilitating physical symptoms, migraine ...

The latter isn't going to happen of course. AbbVie recorded sales of more than $1.2 billion for Ubrelvy and partner migraine drug Qulipta for episodic and chronic migraine prevention last year.

Give yourself a thumbs-up, then take a closer look. If your thumb’s tip extends back toward your knuckle more than 50 degrees, you may have hitchhiker’s thumb. The nickname replaces its more ...

If you have migraines and you also have frequent sneezing and congestion, you may be surprised to know that there's a potential connection between your head pain and your sniffles. Migraines are more ...

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a ...

It could also be indirectly triggered by a nervous system reaction to the allergy, causing a migraine. Not everyone who has allergies will experience headaches. There is currently no universally ...